Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII

M. Leverkus*, A. Ambach, M. Hoefeld-Fegeler, J. Kohlhase, E. Schmidt, H. Schumann, C. Has, H. Gollnick

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Dystrophic epidermolysis bullosa (DEB) is a rare hereditary skin disorder caused by mutations in COL7A1, encoding collagen type VII.1 Clinical manifestations of COL7A1 mutations range from generalized skin blistering to mild localized blistering or nail dystrophy.2 The investigation of the molecular basis of DEB has revealed more than 540 different mutations that cannot entirely explain phenotypic variations (HGMD® Professional 2010.3, https://portal.biobase-international. com/hgmd/). Inversa recessive DEB (RDEB-I) is a subtype characterized by generalized blistering in the neonatal period. The condition improves with age, and in adults blistering is restricted to intertriginous areas, and severe lesions of the oral and genital mucosa and nail changes occur in the majority of described patients.2 Recent data suggested that amino-acid substitutions affecting arginines or glycines at borders of collagenic subdomains might cause this phenotype.3 We report a German patient with an unusually mild RDEB-I harbouring compound heterozygous mutations in COL7A1.
OriginalspracheEnglisch
ZeitschriftBritish Journal of Dermatology
Jahrgang164
Ausgabenummer5
Seiten (von - bis)1104-1106
Seitenumfang3
ISSN0007-0963
DOIs
PublikationsstatusVeröffentlicht - 01.05.2011

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren